Correction to: Cinnamon extract induces tumor cell death through inhibition of NFκB and AP1(BMC Cancer (2010) 10 (392) DOI: 10.1186/1471-2407-10-392);Cinnamon extract induces tumor cell death through inhibition of NFκB and AP1

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Kwon, Ho Keun ^a   Hwang, Ji Sun ^a   So, Jae Seon ^a   Lee, Choong Gu ^a   Sahoo, Anupama ^a   Ryu, Jae Ha ^a   Jeon, Won K ^b   Ko, Byoung S ^b   Im, Chang Rok ^c   Lee, Sung H ^d   Park, Zee Y ^a   Im, Sin Hyeog ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c Bugil Academy   (South Korea)

^d Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CINNAMON EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; SURVIVIN; ANTINEOPLASTIC AGENT; LUCIFERASE; MESSENGER RNA; PLANT EXTRACT; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL DEATH; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; MALE; MELANOMA; MOUSE; NONHUMAN; TUMOR CELL; TUMOR CELL LINE; UPREGULATION; UTERINE CERVIX CANCER; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; CINNAMOMUM ZEYLANICUM; COLORECTAL TUMOR; DRUG EFFECT; EXPERIMENTAL MELANOMA; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CINNAMOMUM ZEYLANICUM; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUCIFERASES; LYMPHOMA; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NF-KAPPA B; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 77954800100     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-019-6342-5     Document Type: Erratum

References (36)

1. Miller JL, Binns HJ, Brickman WJ. Complementary and Alternative Medicine Use in Children with Type 1 Diabetes: A Pilot Survey of Parents. EXPLORE: The Journal of Science and Healing 2008, 4(5):311-314.
2. Esmonde L, Long AF. Complementary therapy use by persons with multiple sclerosis: Benefits and research priorities. Complementary Therapies in Clinical Practice 2008, 14(3):176-184. 10.1016/j.ctcp.2008.03.001, 18640629.
3. Ernst E. Complementary/alternative medicine for disease prevention: The good, the bad and the ugly. Preventive Medicine 49(2-3):77. 10.1016/j.ypmed.2009.08.006, 19782247.
4. Längler A, Kaatsch P, Spix C, Seifert G. Complementary and alternative treatment methods in children with cancer. A population based retrospective survey on the prevalence of use in Germany. European Journal of Integrative Medicine 2008, 1(Supplement 1):10.
5. Tanaka T. Chemical studies on plant polyphenols and formation of black tea polyphenols. Yakugaku Zasshi 2008, 128(8):1119-1131. 10.1248/yakushi.128.1119, 18670177.
6. Wijesekera RO. Historical overview of the cinnamon industry. CRC critical reviews in food science and nutrition 1978, 10(1):1-30. 10.1080/10408397809527243, 363362.
7. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes. Diabetes Care 2003, 26(12):3215-3218. 10.2337/diacare.26.12.3215, 14633804.
8. Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. Journal of Ethnopharmacology 2006, 104(1-2):119-123. 10.1016/j.jep.2005.08.059, 16213119.
9. Lee J-S, Jeon S-M, Park E-M, Huh T-L, Kwon O-S, Lee M-K, Choi M-S. Cinnamate Supplementation Enhances Hepatic Lipid Metabolism and Antioxidant Defense Systems in High Cholesterol-Fed Rats. Journal of Medicinal Food 2003, 6(3):183-191. 10.1089/10966200360716599, 14585184.
10. Matan N, Rimkeeree H, Mawson AJ, Chompreeda P, Haruthaithanasan V, Parker M. Antimicrobial activity of cinnamon and clove oils under modified atmosphere conditions. International Journal of Food Microbiology 2006, 107(2):180-185. 10.1016/j.ijfoodmicro.2005.07.007, 16266767.
11. Schoene NW, Kelly MA, Polansky MM, Anderson RA. Water-soluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. Cancer Letters 2005, 230(1):134-140. 10.1016/j.canlet.2004.12.039, 16253769.
12. Youn HS, Lee JK, Choi YJ, Saitoh SI, Miyake K, Hwang DH, Lee JY. Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochemical Pharmacology 2008, 75(2):494-502. 10.1016/j.bcp.2007.08.033, 17920563.
13. Kamei T, Kumano H, Iwata K, Nariai Y, Matsumoto T. The Effect of a Traditional Chinese Prescription for a Case of Lung Carcinoma. The Journal of Alternative and Complementary Medicine 2000, 6(6):557-559. 10.1089/acm.2000.6.557, 11152062.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66. 10.3322/canjclin.57.1.43, 17237035.
15. Escarcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A. The Transcription Factor Nuclear Factor-kappa B and Cancer. Clinical Oncology 2007, 19(2):154-161. 10.1016/j.clon.2006.11.013, 17355113.
16. Cassileth BR. Complementary and alternative cancer medicine. Journal of Clinical Oncology 1999, 17(11 SUPPL):44-52.
17. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002, 2(10):727-739. 10.1038/nrc905, 12360276.
18. Tascilar M, de Jong FA, Verweij J, Mathijssen RHJ. Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence. Oncologist 2006, 11(7):732-741. 10.1634/theoncologist.11-7-732, 16880232.
19. Karin M, Cao Y, Greten FR, Li Z-W. NF-[kappa]B in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002, 2(4):301. 10.1038/nrc780, 12001991.
20. Garg A, Aggarwal BB. Nuclear transcription factor-kappa B as a target for cancer drug development. Leukemia 2002, 16:1053-1068. 10.1038/sj.leu.2402482, 12040437.
21. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene 2001, 20(19 REV. ISS. 2):2401-2412. 10.1038/sj.onc.1204389, 11402336.
22. Kwon H-K, Jeon WK, Hwang J-S, Lee C-G, So J-S, Park J-A, Ko BS, Im S-H. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells. Cancer letters 2009, 278(2):174-182. 10.1016/j.canlet.2009.01.015, 19203831.
23. Taylor IW. A rapid single step staining technique for DNA analysis by flow microfluorimetry. J Histochem Cytochem 1980, 28(9):1021-1024.
24. Norberta WS, Meghan AK, Marilyn MP, Richard AA. Water-soluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. Cancer letters 2005, 230(1):134-140. 10.1016/j.canlet.2004.12.039, 16253769.
25. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Molecular Immunology 2003, 39(11):615-647. 10.1016/S0161-5890(02)00252-3, 12493639.
26. Karin M, Cao Y, Greten FR, Li Z-W. NF-[kappa]B in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002, 2(4):301-310. 10.1038/nrc780, 12001991.
27. Karin M, Lin A. NF-[kappa]B at the crossroads of life and death. Nat Immunol 2002, 3(3):221-227. 10.1038/ni0302-221, 11875461.
28. Ioannou YA, Chen FW. Quantitation of DNA fragmentation in apoptosis. Nucl Acids Res 1996, 24(5):992-993. 10.1093/nar/24.5.992, 145716, 8600475.
29. Stadelmann C, Lassmann H. Detection of apoptosis in tissue sections. Cell and Tissue Research 2000, 301(1):19-31. 10.1007/s004410000203, 10928278.
30. Wijesekera RO. Historical overview of the cinnamon industry. CRC critical reviews in food science and nutrition 1978, 10(1):1. 10.1080/10408397809527243, 363362.
31. Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature 2000, 407(6805):810-816. 10.1038/35037747, 11048733.
32. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005, 5(11):876-885. 10.1038/nrc1736, 16239906.
33. Croce CM. Oncogenes and Cancer. N Engl J Med 2008, 358(5):502-511. 10.1056/NEJMra072367, 18234754.
34. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell 2000, 100(1):57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
35. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B. Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms. Journal of Biological Chemistry 2004, 279(24):25535-25543. 10.1074/jbc.M400944200, 15054096.
36. Eliaz RE, Nir S, Marty C, Szoka FC. Determination and Modeling of Kinetics of Cancer Cell Killing by Doxorubicin and Doxorubicin Encapsulated in Targeted Liposomes. Cancer Res 2004, 64(2):711-718. 10.1158/0008-5472.CAN-03-0654, 14744789.